Compare FRD & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRD | MOBI |
|---|---|---|
| Founded | 1965 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.2M | 383.0M |
| IPO Year | 1995 | 2026 |
| Metric | FRD | MOBI |
|---|---|---|
| Price | $38.85 | $12.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 40.7K | ★ 166.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.96 | N/A |
| Revenue | ★ $121,157,278.00 | N/A |
| Revenue This Year | N/A | $71.88 |
| Revenue Next Year | N/A | $43.02 |
| P/E Ratio | $9.92 | ★ N/A |
| Revenue Growth | ★ 55.82 | N/A |
| 52 Week Low | $16.55 | $8.03 |
| 52 Week High | $48.77 | $15.19 |
| Indicator | FRD | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 64.74 |
| Support Level | $36.88 | $10.70 |
| Resistance Level | $43.92 | $13.85 |
| Average True Range (ATR) | 2.11 | 1.08 |
| MACD | -0.48 | 0.20 |
| Stochastic Oscillator | 47.73 | 79.69 |
Friedman Industries Inc is a manufacturer and processor of metals and operates in two reportable segments: flat-roll products and tubular products. The flat-roll product segment consists of flat-roll processing facilities located in Hickman, Arkansas; Decatur, Alabama; Miami, Florida; East Chicago, Indiana; Granite City, Illinois and Sinton, Texas and a flat-roll distribution facility located in Orlando, Florida. The tubular product segment consists of the Company's Texas Tubular Products division (TTP) located in Lone Star, Texas. TTP operates two electric resistance welded pipe mills with a combined outside diameter (OD). Its products are flat-roll products and tubular products.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.